Moss Adams Wealth Advisors LLC Gilead Sciences, Inc. Transaction History
Moss Adams Wealth Advisors LLC
- $950 Billion
- Q1 2025
A detailed history of Moss Adams Wealth Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Moss Adams Wealth Advisors LLC holds 3,700 shares of GILD stock, worth $404,521. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,700
Previous 3,114
18.82%
Holding current value
$404,521
Previous $288 Million
44.13%
% of portfolio
0.04%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding GILD
# of Institutions
2,287Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.8 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.51 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.97 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.85 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $137B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...